NSC668036（Cat No.:I011309）is a small-molecule compound under investigation for its potential in cancer therapy. It acts as an inhibitor of specific signaling pathways that are crucial for tumor growth and survival. By targeting these pathways, NSC668036 aims to disrupt the proliferation of cancer cells and inhibit their ability to metastasize. Preclinical studies suggest that NSC668036 may be effective in treating certain types of cancer, including those resistant to conventional therapies. Researchers are currently exploring its efficacy and safety in clinical trials to determine its potential as a targeted therapeutic agent in oncology.